Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation

BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 2 Oct 2021)

 

Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation
Genetic testing has potential roles in identifying whether an individual would have risk of adverse drug reactions (ADRs) from a particular medicine. Robust cost-effectiveness results on genetic testing would …
Authors: Saowalak Turongkaravee, Jiraphun Jittikoon, Onwipa Rochanathimoke, Kathleen Boyd, Olivia Wu and Usa Chaikledkaew
Citation: BMC Health Services Research 2021 21:1042
Content type: Research article
Published on: 2 October 2021